A. ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM (BVS)
1012462-12
Introduction
Recalled Products
A. ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM (BVS)
Reason
Abbott Vascular has recently published the results of Absorb III, a clinical trial that compared the safety and effectiveness of Absorb BVS to the XIENCE, metallic drug eluting stent. Learnings from an analysis of the Absorb III data and other published data have identified an impact on clinical outcomes following changes to procedural techniques. Implementation of these techniques is expected to facilitate optimal clinical outcomes and reduce the possibility of thrombosis. Abbott Vascular will be updating the instructions for use (IFU) with this information.